MALOBERTI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 28.082
AS - Asia 18.679
EU - Europa 12.902
SA - Sud America 2.568
Continente sconosciuto - Info sul continente non disponibili 1.379
AF - Africa 403
OC - Oceania 22
Totale 64.035
Nazione #
US - Stati Uniti d'America 26.537
SG - Singapore 7.786
IT - Italia 4.299
CN - Cina 3.241
VN - Vietnam 2.824
HK - Hong Kong 1.961
BR - Brasile 1.879
RU - Federazione Russa 1.847
DE - Germania 1.712
SE - Svezia 1.193
CA - Canada 1.163
IE - Irlanda 856
GB - Regno Unito 636
IN - India 588
FR - Francia 536
BD - Bangladesh 418
FI - Finlandia 301
KR - Corea 300
UA - Ucraina 247
AR - Argentina 240
AT - Austria 238
ID - Indonesia 227
ES - Italia 203
IQ - Iraq 201
TR - Turchia 181
MX - Messico 168
NL - Olanda 161
PL - Polonia 159
PK - Pakistan 149
ZA - Sudafrica 146
JP - Giappone 142
DK - Danimarca 121
EC - Ecuador 117
PH - Filippine 94
SA - Arabia Saudita 91
CO - Colombia 88
VE - Venezuela 83
UZ - Uzbekistan 57
CZ - Repubblica Ceca 55
BE - Belgio 54
CL - Cile 46
KE - Kenya 46
AE - Emirati Arabi Uniti 43
JM - Giamaica 42
MA - Marocco 42
LT - Lituania 41
PY - Paraguay 41
CR - Costa Rica 40
MY - Malesia 40
CH - Svizzera 39
NP - Nepal 37
JO - Giordania 36
RO - Romania 32
EG - Egitto 31
AZ - Azerbaigian 29
AL - Albania 28
TN - Tunisia 28
UY - Uruguay 27
PE - Perù 26
ET - Etiopia 24
IR - Iran 23
LB - Libano 22
HN - Honduras 21
TH - Thailandia 21
DZ - Algeria 20
IL - Israele 20
GR - Grecia 19
PA - Panama 19
PT - Portogallo 17
TT - Trinidad e Tobago 17
KG - Kirghizistan 16
KZ - Kazakistan 16
BG - Bulgaria 15
AU - Australia 14
OM - Oman 14
BO - Bolivia 13
LV - Lettonia 13
NG - Nigeria 13
NI - Nicaragua 13
PS - Palestinian Territory 13
SY - Repubblica araba siriana 13
SK - Slovacchia (Repubblica Slovacca) 12
PR - Porto Rico 11
TW - Taiwan 11
BY - Bielorussia 10
DO - Repubblica Dominicana 10
AO - Angola 9
BH - Bahrain 9
GT - Guatemala 9
KH - Cambogia 9
EU - Europa 8
LK - Sri Lanka 8
NZ - Nuova Zelanda 8
SV - El Salvador 8
HR - Croazia 7
SN - Senegal 7
BB - Barbados 6
BS - Bahamas 6
CG - Congo 6
EE - Estonia 6
Totale 62.529
Città #
Singapore 3.611
Ann Arbor 3.473
Ashburn 2.892
San Jose 2.323
Hong Kong 1.899
Milan 1.386
Frankfurt am Main 1.153
Chandler 1.135
Ho Chi Minh City 874
Dublin 821
New York 786
Toronto 770
Fairfield 752
Hanoi 732
Los Angeles 641
Wilmington 641
Santa Clara 569
Woodbridge 567
Beijing 564
Council Bluffs 540
Houston 531
Dallas 525
Hefei 479
Chicago 424
Seattle 366
Rome 329
Princeton 291
The Dalles 283
Seoul 282
Dearborn 260
Boardman 258
Buffalo 255
Cambridge 253
Jacksonville 222
Shanghai 220
Lauterbourg 216
São Paulo 196
Vienna 193
Moscow 184
Columbus 177
Phoenix 176
Munich 158
Helsinki 154
Orem 152
Jakarta 135
Nanjing 134
Warsaw 116
Montreal 114
Atlanta 111
Tokyo 106
Lawrence 105
London 105
Da Nang 104
Brooklyn 102
Altamura 101
Haiphong 101
Chennai 93
Denver 90
Ottawa 90
Guangzhou 87
Nuremberg 84
Baghdad 82
Johannesburg 80
Pune 74
Stockholm 67
Rio de Janeiro 66
Turin 66
Figino 65
San Diego 65
Amsterdam 64
Fremont 64
Poplar 59
Turku 59
Boston 58
Dong Ket 57
Tashkent 53
Brussels 52
Lappeenranta 52
Naples 51
Mumbai 48
Andover 47
San Francisco 47
Brasília 46
Monza 46
Hải Dương 44
Salt Lake City 44
Biên Hòa 43
Falls Church 43
Palermo 43
Quito 43
Washington 43
Mexico City 42
Manchester 41
Belo Horizonte 40
Tianjin 39
Ankara 38
Charlotte 38
Florence 38
Lahore 38
New Delhi 38
Totale 36.514
Nome #
Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Current Insights into Pathophysiology, Diagnosis, and Management 964
Effects of Chronic Heart Failure Unconventional Therapies on Endothelial Function 622
Type A Personality as the principal psychological determinants of Left Ventricular Mass Index in hypertensive patients 600
Association Between Atrial, Ventricular and Vascular Morphofunctional Alterations in Rheumatoid Arthritis 558
Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry) 534
Effetto della terapia incretinica su funzione e struttura arteriosa in pazienti con diabete mellito tipo 2 531
Sex-related relationships between uric acid and target organ damage in hypertension 509
Predictors of pwv progression over a three years follow up: focus on psychological characteristics 500
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 497
Effects of Renal Sympathetic Denervation on Arterial Stiffness and Blood Pressure Control in Resistant Hypertensive Patients: A Single Centre Prospective Study 478
Is Type A Personality associated with Left Ventricular Mass Index in arterial hypertension? Results of a cross-sectional study 476
Erratum: Effects of Renal Sympathetic Denervation on Arterial Stiffness and Blood Pressure Control in Resistant Hypertensive Patients: A Single Centre Prospective Study [High Blood Press Cardiovasc Prev, DOI 10.1007/s40292-015-0121-4] 475
Arterial Stiffness in Aortic Stenosis: Relationship with Severity and Echocardiographic Procedures Response 463
The Key Role of a Psychoactive Substance Use History in Comprehensive Cardiovascular Risk Assessment, Diagnosis, Treatment, and Prevention 455
Vascular Aging and Disease of the Large Vessels: Role of Inflammation 443
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 432
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 401
Persistence of arterial functional abnormalities after successful coronary revascularization 400
Mycotic coronary aneurysms 400
Comparison of echotracking and magnetic resonance assessment of abdominal aorta distensibility and relationships with pulse wave velocity 399
In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers 399
Does the 9p region affect arterial stiffness? Results from a cohort of hypertensive individuals 392
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 391
Cardiac Biomarkers Release in Preadolescent Athletes After an High Intensity Exercise 386
24-Hour Blood Pressure Monitoring Patterns in HIV-Positive Patients and its Relationship with Arterial Distensibility 382
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 379
A case of Pseudomonas Aeruginosa commercial tattoo infection 378
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 375
[OP.5B.01] Pulse Wave Velocity And Depression In Hypertensive Patients 372
Psychological Predictors of Arterial Stiffness Progression over a Three Years Follow Up 371
Kounis Syndrome: Report of Two Cases with Peculiar Presentation and Diagnostic Issues 371
Cardiovascular Remodeling after Endovascular Treatment for Thoracic Aortic Injury 367
Could two-dimensional radial strain be considered as a novel tool to identify pre-clinical hypertrophic cardiomyopathy mutation carriers? 366
Uric acid in chronic coronary syndromes: Relationship with coronary artery disease severity and left ventricular diastolic parameter 359
Iron stores, hepcidin, and aortic stiffness in individuals with hypertension 352
Thoracic Radiotherapy As A Risk Factor For Heart Ischemia In Subjects Treated With Chest Irradiation And Chemotherapy And Without Classic Cardiovascular RISK Factors 348
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 348
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 346
Functional Improvement After Outpatient Cardiac Rehabilitation in Acute Coronary Syndrome Patients is Not Related to Improvement in Left Ventricular Ejection Fraction 346
Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option 342
Therapeutic Approach to Hypertension Urgencies and Emergencies in the Emergency Room 342
Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios 341
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 341
Ankle-Brachial Index Is a Predictor of In-Hospital Functional Status but Not of Complications in Hospitalized Elderly Patients 337
Association between uric acid and pulse wave velocity in hypertensive patients and in the general population: a systematic review and meta-analysis 335
Structural and Functional Abnormalities of Carotid Artery and Their Relation with EVA Phenomenon 333
Correlation of Ankle-Brachial Index with Frailty Status in Old Hospitalized Patients 333
Brachial and central blood pressure in HIV-infected subjects 329
Pulse wave velocity progressione over a 3.7 years follow-up: focus on metabolic syndrome. 329
Effects of Cancer Therapy Targeting Vascular Endothelial Growth Factor Receptor on Central Blood Pressure and Cardiovascular System 328
Functional improvement after cardiac rehabilitation is not related to improvement in left ventricular ejection fraction 326
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 324
Evaluation of Unattended Automated Office, Conventional Office and Ambulatory Blood Pressure Measurements and Their Correlation with Target Organ Damage in an Outpatient Population of Hypertensives: Study Design and Methodological Aspects 324
Thoracic radiotherapy as a risk factor for heart ischemia in subjects with chest irradiation and without classic cardiovascular risk factors. 314
Sense of Coherence Predicts Physical Activity Maintenance and Health-Related Quality of Life: A 3-Year Longitudinal Study on Cardiovascular Patients 314
Psychological determinants of target organ damage in hypertensive patients: Focus on type A personality and Left Ventricular Mass Index 309
RUOLO DELL’ACIDO URICO NELLA CARDIOPATIA ISCHEMICA ACUTA: RISULTATI DALLA COORTE DEI PAZIENTI CON SINDROME CORONARICA ACUTA DELL’OSPEDALE NIGUARDA 308
A three-year longitudinal study of healthy lifestyle behaviors and adherence to pharmacological treatments in newly diagnosed patients with acute coronary syndrome: hierarchical linear modeling analyses 307
HYPERTENSIVE EMERGENCIES AND URGENCIES: ADHERENCE TO GUIDELIENS AND RELATIONSHIP BETWEEN BLOOD PRESSURE MANAGEMENT AND IN-HOSPITAL MORTALITY 304
Hemodynamic and Functional Effects of 6-Week Cardio-Rehabilitation after Acute Miocardial Infarction, Identification of a NWE Functional Index: Meter/Heart Rate Rario 303
Increased nocturnal heart rate andwave reflection are earlymarkers of cardiovascular disease in Williams-Beuren syndrome children 301
Psychological determinants of target organ damage in hypertensive patients: Focus on Pulse Wave Velocity and depression 298
Hypertensive emergencies and urgencies: blood pressure management and its relationship with short and medium term outcome 297
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 295
1b.01: 24 hour modulation of peripheral and central blood pressure, heart rate and arterial stiffness in heart transplant hypertensive individuals 294
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 294
Hypertensive Emergencies and Urgencies: Blood Pressure Management and its Relationship with Short and Medium Term Outcome 291
Heart rate in patients with sars-cov-2 infection: Prevalence of high values at discharge and relationship with disease severity 289
Hyperuricemia in Cardiac Rehabilitation Patients: Prevalence and Association with Functional Improvement and Left Ventricular Ejection Fraction 286
Effects of Environmental Factors on Severity and Mortality of COVID-19 283
Relationship between vascular damage and left ventricular concentric geometry in patients undergoing coronary angiography: a multicenter prospective study 282
Impact of admission serum acid uric levels on in-hospital outcomes in patients with acute coronary syndrome 282
Protein Intake and Physical Activity in Newly Diagnosed Patients with Acute Coronary Syndrome: A 5-Year Longitudinal Study 282
Long-Term Effects of Radiotherapy on Arterial Stiffness in Breast Cancer Women 281
Aortic Remodeling in Patients with Arterial Hypertension: Pathophysiological Mechanisms, Therapeutic Interventions and Preventive Strategies—A Position Paper from the Heart and Hypertension Working Group of the Italian Society of Hypertension 281
Anderson–Fabry Disease: An Overview of Current Diagnosis, Arrhythmic Risk Stratification, and Therapeutic Strategies 280
La personalità di Tipo A come principale determinante psicologica dell’indice di massa ventricolare sinistra nei pazienti ipertesi 280
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 279
Cardiac amyloidosis red flags: What all the cardiologist have to know 278
IMPORTANCE OF URIC ACID THRESHOLD IN ITS CORRELATION WITH METABOLIC SYNDROME 276
Heart structure and vascular function in young patients after endovascular repair for blunt thoracic aortic injury 275
Pressione centrale delle 24h e arterial stiffnes in soggetti sottoposti a trapianto cardiaco: non dipping phenomenon 274
What hypertensive patients want to know [and from whom] about their disease: a two-year longitudinal study 274
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 273
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 270
Evaluation of the effects of monacolin k on lipid profile and arterial function in dyslipidemic patients. 269
Arterial structure and function in AIDS patients: the impact of renal damage. 268
Determinants of Functional Improvement After Cardiac Rehabilitation in Acute Coronary Syndrome 268
Annexin A5 in treated hypertensive patients and its association with target organ damage 267
The role of uric acid in acute and chronic coronary syndromes 267
Elevated Serum Urea-to-Creatinine Ratio and In-Hospital Death in Patients with Hyponatremia Hospitalized for COVID-19 266
C68 RESTING HEART RATE AND ARTERIAL STIFFNESS: A LONGITUDINAL PROSPECTIVE STUDY IN A POPULATION OF HYPERTENSIVE PATIENTS 266
Atrial Fibrillation Incidence in SARS-COV-2 Infected Patients: Predictors and Relationship with in-Hospital Mortality 266
Arrhythmic Risk Stratification in Cardiac Amyloidosis: A Review of the Current Literature 266
Thoracic radiotherapy as a risk factor for heart ischemia in subjects with chest irradiation and without classic cardiovascular risk factors 264
Lipoproteina(a): associazione con la malattia aterosclerotica e valvolare e terapie emergenti 262
Psychological determinants of target organ damage in hypertensive patients: focus on type A Personality and Left Ventricular Mass Index 262
Type A personality as the principal psychological determinants of left ventricular mass index in hypertensive patients 262
Importance of uric acid threshold in its correlation with metabolic syndrome 262
Prevalence of hypertension mediated organ damage in subjects with high-normal blood pressure without known hypertension as well as cardiovascular and kidney disease 260
Totale 35.058
Categoria #
all - tutte 202.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 202.684


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.832 0 0 0 271 178 213 88 112 153 190 201 426
2022/20234.716 442 1.209 488 455 371 667 106 316 298 91 152 121
2023/20243.616 96 134 241 254 430 865 564 137 253 70 75 497
2024/202511.418 430 838 513 587 771 397 555 340 1.092 1.608 1.881 2.406
2025/202626.701 3.353 1.649 1.783 2.978 3.056 1.262 3.802 1.083 2.109 2.285 1.466 1.875
2026/20275.694 1.263 1.487 2.789 155 0 0 0 0 0 0 0 0
Totale 64.035